O2h Ventures Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
3
- Investments
-
70
- Portfolio
-
38
- Exits
-
11
O2h Ventures General Information
Company Description
Founded in 2018, O2h Ventures is a venture capital firm based in Cambridge, United Kingdom. The firm seeks to invest in healthcare, life science, information technology, artificial intelligence & health technology sectors based in the United Kingdom region.
Business Details
Website
o2hventures.comYear Founded
Investor Status
Primary Investor Type
Other Investor Types
Corporate Office
- Hauxton House
- The Mill SciTech Park, Mill Lane
- Cambridge CB22 5HX
- England, United Kingdom
O2h Ventures Investments (70)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Enedra Therapeutics | 08-May-2025 | Early Stage VC | Drug Discovery | Clinical Trials - General | ||
| Qkine | 21-Mar-2025 | Biotechnology | Generating Revenue | |||
| Monument Therapeutics | 25-Feb-2025 | Drug Discovery | Clinical Trials - Phase 1 | |||
| Atelerix | 28-Jan-2025 | Biotechnology | Generating Revenue | |||
| Revolver Therapeutics | 15-Nov-2024 | Biotechnology | Startup | |||
| PhoreMost | 10-Sep-2024 | Biotechnology | Pre-Clinical Trials | |||
| Clotprotect | 02-May-2024 | Discovery Tools (Healthcare) | Startup | |||
| Vesynta | 05-Apr-2024 | Decision/Risk Analysis | Generating Revenue | |||
| AscendBio | 01-Apr-2024 | Early Stage VC | Drug Discovery | Startup | ||
| CamGene Therapeutics | 02-Feb-2024 | Early Stage VC | Biotechnology | Generating Revenue |
O2h Ventures Exits (11)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Opal Oncology | 28-May-2024 | Out of Business | |
| Iota Pharmaceuticals | 14-Nov-2023 | ||
| Repositive | 12-Nov-2021 | ||
| BiVictrix Therapeutics | 11-Aug-2021 | ||
| Arecor Therapeutics | 03-Jun-2021 | ||
| Small Pharma | 29-Apr-2021 | ||
| Zephx | 01-Sep-2020 | ||
| Privitar | 22-Jun-2020 | ||
| LaborVoices | 06-Sep-2019 | Out of Business | |
| Absynth Biologics | 01-Jan-2019 | Out of Business |
O2h Ventures Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
O2h Ventures Co-Investors (73)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Meltwind Advisory | 13 |
|
|
||
| SyndicateRoom |
|
|
|||
| Cambridge Angels |
|
|
|||
| ACF Investors |
|
|
|||
| Parkwalk Advisors |
|
|
O2h Ventures FAQs
-
What is O2h Ventures?
Founded in 2018, O2h Ventures is a venture capital firm based in Cambridge, United Kingdom.
-
When was O2h Ventures founded?
O2h Ventures was founded in 2018.
-
Where is O2h Ventures headquartered?
O2h Ventures is headquartered in Cambridge, United Kingdom.
-
How many investments has O2h Ventures made?
O2h Ventures has made 70 investments.
-
What has O2h Ventures invested in?
O2h Ventures has made numerous investments in companies like Enedra Therapeutics, Qkine, and Monument Therapeutics within the Drug Discovery and Biotechnology industries.
-
What has O2h Ventures invested in recently?
O2h Ventures's latest investment was on 08-May-2025 in Enedra Therapeutics, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
